Association between the use of magnesium sulfate as neuroprotector in prematurity and the neonatal hemodynamic effects.
Autor: | Nunes RD; a Graduate Program in Health Sciences , Universidade do Sul de Santa Catarina , Palhoca , Brazil., Schutz FD; a Graduate Program in Health Sciences , Universidade do Sul de Santa Catarina , Palhoca , Brazil., Traebert JL; a Graduate Program in Health Sciences , Universidade do Sul de Santa Catarina , Palhoca , Brazil. |
---|---|
Jazyk: | angličtina |
Zdroj: | The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians [J Matern Fetal Neonatal Med] 2018 Jul; Vol. 31 (14), pp. 1900-1905. Date of Electronic Publication: 2017 Jun 02. |
DOI: | 10.1080/14767058.2017.1332033 |
Abstrakt: | Purpose: Cerebral palsy is often associated with prematurity and magnesium sulfate (MgSO Materials and Methods: A cross-sectional study involving 94 newborns (NB) between 24 and 32 weeks at a Brazilian hospital was performed. Bivariate analysis between the use or the non-use of MgSO Results: NB were evaluated between those who received MgSO Conclusions: MgSO |
Databáze: | MEDLINE |
Externí odkaz: |